Gender and Age Differences in ADHD Symptoms and Co-occurring Depression and Anxiety Symptoms Among Children and Adolescents in the BELLA Study.

ADHD Adolescents Anxiety Depression Gender differences Mental health

Journal

Child psychiatry and human development
ISSN: 1573-3327
Titre abrégé: Child Psychiatry Hum Dev
Pays: United States
ID NLM: 1275332

Informations de publication

Date de publication:
18 Oct 2023
Historique:
accepted: 09 10 2023
medline: 18 10 2023
pubmed: 18 10 2023
entrez: 18 10 2023
Statut: aheadofprint

Résumé

Attention-deficit/hyperactivity disorder (ADHD) is one of the most diagnosed neurodevelopmental disorders of childhood. Current studies addressing gender and age differences in ADHD are lacking. The present study aims to fill this research gap by dimensionally evaluating gender and age differences in ADHD symptoms, as measured by a DSM-5-based parent rating scale, in children and adolescents who participated in the two-year follow-up of the community-based BELLA study (n = 1326). Associations between ADHD symptoms and depression symptoms and anxiety symptoms were also examined. Multiple linear regressions revealed significant associations between gender and all ADHD symptoms. Age was significantly associated with hyperactive/impulsive symptoms. Additional multiple linear regressions demonstrated significant positive associations between depression and anxiety symptoms and ADHD symptoms. Further, female gender was found to be positively associated with both depression and anxiety symptoms. These findings may suggest a need for more gender-specific approaches to ADHD diagnosis and treatment, as well as more research into the intersections of ADHD and depression and anxiety symptoms in children and adolescents.

Identifiants

pubmed: 37851158
doi: 10.1007/s10578-023-01622-w
pii: 10.1007/s10578-023-01622-w
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2023. The Author(s).

Références

American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders: DSM-5, 5th edn. American Psychiatric Association, Virginia
doi: 10.1176/appi.books.9780890425596
World Health Organization (2004) ICD-10: international statistical classification of diseases and related health problems: tenth revision. World Health Organization, Geneva
Asherson P (2016) ADHD across the lifespan. Medicine 44(11):683–686. https://doi.org/10.1016/j.mpmed.2016.08.012
doi: 10.1016/j.mpmed.2016.08.012
Faraone SV, Banaschewski T, Coghill D, Zheng Y, Biederman J, Bellgrove MA, Newcorn JH, Gignac M, Al Saud NM, Manor I, Rohde LA, Yang L, Cortese S, Almagor D, Stein MA, Albatti TH, Aljoudi HF, Alqahtani MMJ, Asherson P, Wang Y (2021) The world federation of ADHD international consensus statement: 208 evidence-based conclusions about the disorder. Neurosci Biobehav Rev 128:789–818. https://doi.org/10.1016/j.neubiorev.2021.01.022
doi: 10.1016/j.neubiorev.2021.01.022 pubmed: 33549739 pmcid: 8328933
Riley AW, Spiel G, Coghill D, Döpfner M, Falissard B, Lorenzo MJ, Preuss U, Ralston SJ, ADORE Study Group (2006) Factors related to health-related quality of Life (HRQoL) among children with ADHD in Europe at entry into treatment. Eur Child Adolesc Psychiatry 15(S1):i38–i45. https://doi.org/10.1007/s00787-006-1006-9
doi: 10.1007/s00787-006-1006-9 pubmed: 17177014
Krauss A, Schellenberg C (2022) ADHD symptoms and health-related quality of life of adolescents and young adults. Eur J Health Psychol. https://doi.org/10.1027/2512-8442/a000104
doi: 10.1027/2512-8442/a000104
Arolt V (2008) Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung. Nervenarzt 79(7):769–770. https://doi.org/10.1007/s00115-008-2506-2
doi: 10.1007/s00115-008-2506-2 pubmed: 18548225
Breda V, Rohde LA, Menezes AMB, Anselmi L, Caye A, Rovaris DL, Vitola ES, Bau CHD, Grevet EH (2021) The neurodevelopmental nature of attention-deficit hyperactivity disorder in adults. Br J Psychiatry 218(1):43–50. https://doi.org/10.1192/bjp.2020.200
doi: 10.1192/bjp.2020.200 pubmed: 33263274
Okie S (2006) ADHD in adults. N Engl J Med 354(25):2637–2641. https://doi.org/10.1056/NEJMp068113
doi: 10.1056/NEJMp068113 pubmed: 16790695
Polanczyk G, Salum GA, Sugaya LS, Caye A, Rohde LA (2015) Annual research review: a meta-analysis of the worldwide prevalence of mental disorders in children and adolescents. J Child Psychol Psychiatry 56(3):345–365. https://doi.org/10.1111/jcpp.12381
doi: 10.1111/jcpp.12381 pubmed: 25649325
Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA (2007) The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry 164(6):942–948. https://doi.org/10.1176/ajp.2007.164.6.942
doi: 10.1176/ajp.2007.164.6.942 pubmed: 17541055
Willcutt EG (2012) The prevalence of DSM-IV attention-deficit/hyperactivity disorder: a meta-analytic review. Neurotherapeutics 9(3):490–499. https://doi.org/10.1007/s13311-012-0135-8
doi: 10.1007/s13311-012-0135-8 pubmed: 22976615 pmcid: 3441936
Lahey BB, Applegate B, McBurnett K, Biederman J, Greenhill L, Hynd GW, Barkley RA, Newcorn J, Jensen P, Richters J, Garfinkel B, Kerdyk L, Frick PJ, Ollendick T, Perez D, Hart EL, Waidman I, Shaffer D (1994) DMS-IV field trials for attention deficit hyperactivity disorder in children and adolescents. Am J Psychiatry 151(11):1673–1685. https://doi.org/10.1176/ajp.151.11.1673
doi: 10.1176/ajp.151.11.1673 pubmed: 7943460
Clarke DE, Narrow WE, Regier DA, Kuramoto SJ, Kupfer DJ, Kuhl EA, Greiner L, Kraemer HC (2013) DSM-5 field trials in the United States and Canada, part I: study design, sampling strategy, implementation, and analytic approaches. Am J Psychiatry 170(1):43–58. https://doi.org/10.1176/appi.ajp.2012.12070998
doi: 10.1176/appi.ajp.2012.12070998 pubmed: 23111546
Gershon J, Gershon J (2002) A meta-analytic review of gender differences in ADHD. J Atten Disord 5(3):143–154. https://doi.org/10.1177/108705470200500302
doi: 10.1177/108705470200500302 pubmed: 11911007
Young S, Adamo N, Ásgeirsdóttir BB, Branney P, Beckett M, Colley W, Cubbin S, Deeley Q, Farrag E, Gudjonsson G, Hill P, Hollingdale J, Kilic O, Lloyd T, Mason P, Paliokosta E, Perecherla S, Sedgwick J, Skirrow C, Woodhouse E (2020) Females with ADHD: an expert consensus statement taking a lifespan approach providing guidance for the identification and treatment of attention-deficit/hyperactivity disorder in girls and women. BMC Psychiatry 20(1):404. https://doi.org/10.1186/s12888-020-02707-9
doi: 10.1186/s12888-020-02707-9 pubmed: 32787804 pmcid: 7422602
Graetz BW, Sawyer MG, Baghurst P (2005) Gender differences among children with DSM-IV ADHD in Australia. J Am Acad Child Adolesc Psychiatry 44(2):159–168. https://doi.org/10.1097/00004583-200502000-00008
doi: 10.1097/00004583-200502000-00008 pubmed: 15689729
Ohan JL, Johnston C (2005) Gender appropriateness of symptom criteria for attention-deficit/hyperactivity disorder, oppositional-defiant disorder, and conduct disorder. Child Psychiatry Hum Dev 35(4):359–381. https://doi.org/10.1007/s10578-005-2694-y
doi: 10.1007/s10578-005-2694-y pubmed: 15886870
Mowlem F, Agnew-Blais J, Taylor E, Asherson P (2019) Do different factors influence whether girls versus boys meet ADHD diagnostic criteria? Sex differences among children with high ADHD symptoms. Psychiatry Res 272:765–773. https://doi.org/10.1016/j.psychres.2018.12.128
doi: 10.1016/j.psychres.2018.12.128 pubmed: 30832197 pmcid: 6401208
Quinn PO, Madhoo M (2014) A review of attention-deficit/hyperactivity disorder in women and girls: uncovering this hidden diagnosis. Prim Care Companion CNS Disord. https://doi.org/10.4088/PCC.13r01596
doi: 10.4088/PCC.13r01596 pubmed: 25317366 pmcid: 4195638
Franke B, Michelini G, Asherson P, Banaschewski T, Bilbow A, Buitelaar JK, Cormand B, Faraone SV, Ginsberg Y, Haavik J, Kuntsi J, Larsson H, Lesch K-P, Ramos-Quiroga JA, Réthelyi JM, Ribases M, Reif A (2018) Live fast, die young? A review on the developmental trajectories of ADHD across the lifespan. Eur Neuropsychopharmacol 28(10):1059–1088. https://doi.org/10.1016/j.euroneuro.2018.08.001
doi: 10.1016/j.euroneuro.2018.08.001 pubmed: 30195575 pmcid: 6379245
Ramtekkar UP, Reiersen AM, Todorov AA, Todd RD (2010) Sex and age differences in attention-deficit/hyperactivity disorder symptoms and diagnoses: implications for DSM-V and ICD-11. J Am Acad Child Adolesc Psychiatry 49(3):217–228
pubmed: 20410711 pmcid: 3101894
Ghandour RM, Sherman LJ, Vladutiu CJ, Ali MM, Lynch SE, Bitsko RH, Blumberg SJ (2019) Prevalence and treatment of depression, anxiety, and conduct problems in US children. J Pediatr 206:256-267e3. https://doi.org/10.1016/j.jpeds.2018.09.021
doi: 10.1016/j.jpeds.2018.09.021 pubmed: 30322701
Gillberg C, Gillberg IC, Rasmussen P, Kadesjö B, Söderström H, Råstam M, Johnson M, Rothenberger A, Niklasson L (2004) Co-existing disorders in ADHD -- implications for diagnosis and intervention. Eur Child Adolesc Psychiatry 13(Suppl 1):I80–92. https://doi.org/10.1007/s00787-004-1008-4
doi: 10.1007/s00787-004-1008-4 pubmed: 15322959
Meinzer MC, Pettit JW, Viswesvaran C (2014) The co-occurrence of attention-deficit/hyperactivity disorder and unipolar depression in children and adolescents: a meta-analytic review. Clin Psychol Rev 34(8):595–607. https://doi.org/10.1016/j.cpr.2014.10.002
doi: 10.1016/j.cpr.2014.10.002 pubmed: 25455624
Balázs J, Keresztény Á (2014) Subthreshold attention deficit hyperactivity in children and adolescents: a systematic review. Eur Child Adolesc Psychiatry 23(6):393–408. https://doi.org/10.1007/s00787-013-0514-7
doi: 10.1007/s00787-013-0514-7 pubmed: 24399038
Ravens-Sieberer U, Otto C, Kriston L, Rothenberger A, Döpfner M, Herpertz-Dahlmann B, Barkmann C, Schön G, Hölling H, Schulte-Markwort M, Klasen F, The BELLA study group (2015) The longitudinal BELLA study: design, methods and first results on the course of mental health problems. Eur Child Adolesc Psychiatry 24(6):651–663. https://doi.org/10.1007/s00787-014-0638-4
doi: 10.1007/s00787-014-0638-4 pubmed: 25428179
Brauns H, Scherer S, Steinmann S (2003) The CASMIN educational classification in international comparative research. In: Hoffmeyer-Zlotnik JHP, Wolf C (eds) Advances in cross-national comparison. Springer, Berlin, pp 221–244. https://doi.org/10.1007/978-1-4419-9186-7_11
doi: 10.1007/978-1-4419-9186-7_11
Schenk L, Bau A-M, Borde T, Butler J, Lampert T, Neuhauser H, Razum O, Weilandt C (2006) Mindestindikatorensatz Zur Erfassung Des Migrationsstatus: Empfehlungen für die epidemiologische Praxis. Bundesgesundheitsblatt-Gesundheitsforschung-Gesundheitsschutz 49(9):853–860. https://doi.org/10.1007/s00103-006-0018-4
doi: 10.1007/s00103-006-0018-4 pubmed: 16927038
Döpfner M, Görtz-Dorten A, Lehmkuhl G (2017) DISYPS-III: Diagnostik-System für Psychische Störungen Nach ICD-10 und DSM-5 für Kinder Und Jugendliche—III; Manual. Hogrefe. https://books.google.de/books?id=hfHmtAEACAAJ
Erhart M, Döpfner M, Ravens-Sieberer U, The BELLA study group (2008) Psychometric properties of two ADHD questionnaires: comparing the Conners’ scale and the FBB-HKS in the general population of German children and adolescents—results of the BELLA study. Eur Child Adolesc Psychiatry 17(1):106–115. https://doi.org/10.1007/s00787-008-1012-1
doi: 10.1007/s00787-008-1012-1 pubmed: 19132310
Barkmann C, Erhart M, Schulte-Markwort M, The BELLA Study Group (2008) The German version of the centre for epidemiological studies depression scale for children: psychometric evaluation in a population-based survey of 7 to 17 years old children and adolescents—results of the BELLA study. Eur Child Adolesc Psychiatry 17(1):116–124. https://doi.org/10.1007/s00787-008-1013-0
doi: 10.1007/s00787-008-1013-0 pubmed: 19132311
Radloff LS (1977) The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1(3):385–401. https://doi.org/10.1177/014662167700100306
doi: 10.1177/014662167700100306
Birmaher B, Brent DA, Chiappetta L, Bridge J, Monga S, Baugher M (1999) Psychometric properties of the screen for child anxiety related emotional disorders (SCARED): a replication study. J Am Acad Child Adolesc Psychiatry 38(10):1230–1236. https://doi.org/10.1097/00004583-199910000-00011
doi: 10.1097/00004583-199910000-00011 pubmed: 10517055
Weitkamp K, Romer G, Rosenthal S, Wiegand-Grefe S, Daniels J (2010) German screen for child anxiety related emotional disorders (SCARED): reliability, validity, and cross-informant agreement in a clinical sample. Child Adolesc Psychiatry Mental Health 4(1):19. https://doi.org/10.1186/1753-2000-4-19
doi: 10.1186/1753-2000-4-19
Reiss F, Meyrose A-K, Otto C, Lampert T, Klasen F, Ravens-Sieberer U (2019) Socioeconomic status, stressful life situations and mental health problems in children and adolescents: results of the German BELLA cohort-study. PLoS ONE 14(3):e0213700. https://doi.org/10.1371/journal.pone.0213700
doi: 10.1371/journal.pone.0213700 pubmed: 30865713 pmcid: 6415852
Wüstner A, Otto C, Schlack R, Hölling H, Klasen F, Ravens-Sieberer U (2019) Risk and protective factors for the development of ADHD symptoms in children and adolescents: results of the longitudinal BELLA study. PLoS ONE 14(3):e0214412. https://doi.org/10.1371/journal.pone.0214412
doi: 10.1371/journal.pone.0214412 pubmed: 30908550 pmcid: 6433344
Faul F, Erdfelder E, Buchner A, Lang A-G (2009) Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses. Behav Res Methods 41(4):1149–1160. https://doi.org/10.3758/BRM.41.4.1149
doi: 10.3758/BRM.41.4.1149 pubmed: 19897823
Cohen J (1992) A power primer. Psychol Bull 112(1):155–159. https://doi.org/10.1037/0033-2909.112.1.155
doi: 10.1037/0033-2909.112.1.155 pubmed: 19565683
Alexander SJ, Harrison AG (2013) Cognitive responses to stress, depression, and anxiety and their relationship to ADHD symptoms in First Year psychology students. J Atten Disord 17(1):29–37. https://doi.org/10.1177/1087054711413071
doi: 10.1177/1087054711413071 pubmed: 21825110
Riglin L, Leppert B, Dardani C, Thapar AK, Rice F, O’Donovan MC, Smith D, Stergiakouli G, Tilling E, K., Thapar A (2021) ADHD and depression: investigating a causal explanation. Psychol Med 51(11):1890–1897. https://doi.org/10.1017/S0033291720000665
doi: 10.1017/S0033291720000665 pubmed: 32249726
D’Agati E, Curatolo P, Mazzone L (2019) Comorbidity between ADHD and anxiety disorders across the lifespan. Int J Psychiatry Clin Pract 23(4):238–244. https://doi.org/10.1080/13651501.2019.1628277
doi: 10.1080/13651501.2019.1628277 pubmed: 31232613
Bruchmüller K, Margraf J, Schneider S (2012) Is ADHD diagnosed in accord with diagnostic criteria? Overdiagnosis and influence of client gender on diagnosis. J Consult Clin Psychol 80(1):128–138. https://doi.org/10.1037/a0026582
doi: 10.1037/a0026582 pubmed: 22201328
Daviss WB (2008) A review of co-morbid depression in pediatric ADHD: etiologies, phenomenology, and treatment. J Child Adolesc Psychopharmacol 18(6):565–571. https://doi.org/10.1089/cap.2008.032
doi: 10.1089/cap.2008.032 pubmed: 19108661 pmcid: 2699665
Das D, Cherbuin N, Butterworth P, Anstey KJ, Easteal S (2012) A population-based study of attention deficit/hyperactivity disorder symptoms and associated impairment in middle-aged adults. PLoS ONE 7(2):e31500. https://doi.org/10.1371/journal.pone.0031500
doi: 10.1371/journal.pone.0031500 pubmed: 22347487 pmcid: 3275565
Schmidt S, Brähler E, Petermann F, Koglin U (2012) Komorbide Belastungen Bei Jugendlichen und jungen Erwachsenen Mit ADHS. Z für Psychiatrie Psychologie und Psychother 60(1):015–026. https://doi.org/10.1024/1661-4747/a000094
doi: 10.1024/1661-4747/a000094
Vysniauske R, Verburgh L, Oosterlaan J, Molendijk ML (2020) The effects of physical exercise on functional outcomes in the treatment of ADHD: a meta-analysis. J Atten Disord 24(5):644–654. https://doi.org/10.1177/1087054715627489
doi: 10.1177/1087054715627489 pubmed: 26861158
Shephard E, Zuccolo PF, Idrees I, Godoy PB, Salomone E, Ferrante C, Sorgato P, Catão LF, Goodwin A, Bolton PF, Tye C, Groom MJ, Polanczyk GV (2022) Systematic review and meta-analysis: the science of early-life precursors and interventions for attentiondeficit/ hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 61(2):187–226
doi: 10.1016/j.jaac.2021.03.016 pubmed: 33864938

Auteurs

Martha Gilbert (M)

Department of Child and Adolescent Psychiatry, Psychotherapy, and Psychosomatics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Maren Boecker (M)

Department of Child and Adolescent Psychiatry, Psychotherapy, and Psychosomatics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Franziska Reiss (F)

Department of Child and Adolescent Psychiatry, Psychotherapy, and Psychosomatics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Anne Kaman (A)

Department of Child and Adolescent Psychiatry, Psychotherapy, and Psychosomatics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Michael Erhart (M)

Department of Child and Adolescent Psychiatry, Psychotherapy, and Psychosomatics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Alice Salomon University of Applied Sciences, Berlin, Germany.
Apollon University of Applied Sciences, Bremen, Germany.

Robert Schlack (R)

Department of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany.

Joachim Westenhöfer (J)

Department of Health Sciences, Faculty of Life Sciences, Competence Center Health, Hamburg University of Applied Sciences, Hamburg, Germany.

Manfred Döpfner (M)

Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, Faculty of Medicine, University Hospital Cologne, University of Cologne, Cologne, Germany.

Ulrike Ravens-Sieberer (U)

Department of Child and Adolescent Psychiatry, Psychotherapy, and Psychosomatics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. ravens-sieberer@uke.de.
Department of Child and Adolescent Psychiatry, Psychotherapy, and Psychosomatics, Research Section "Child Public Health", University Medical Center Hamburg-Eppendorf, Martinistraße 52, W 29, 20246, Hamburg, Germany. ravens-sieberer@uke.de.

Classifications MeSH